Funding Innovation: What is the Government's Role in Stem Cell Research?

Friday, March 16, 2007 at 3:15 pm
Pound 107, Harvard Law School

What is (or should be) the government's role in funding scientific and medical innovation?  This panel will discuss that question with a particular emphasis on stem cell research.  The creation of new state-based research infrastructure in the wake of federal stem cell research funding decisions represents an interesting case study concerning the role of government at multiple levels in the funding innovation in a pluralistic society.

Moderator

Dan Brock, Professor of Medical Ethics, Harvard Medical School

Panelists

  • Tricia Brooks, Director of Government Relations, The Christopher Reeve Foundation
  • Sam Crowe, Policy Analyst, The President's Council on Bioethics
  • Glen Gaulton, Executive Vice Dean and Chief Scientific Officer, University of Pennsylvania School of Medicine
  • Heather Howard, Senior Policy Counsel to New Jersey Governor Corzine, Member of the Board of Managers: Stem Cell Institute of New Jersey
  • Mary Richards, Director of Government Relations for the Parkinson's Action Network


Harvard Journal of Law & Technology Sponsors
Baker Botts L.L.P. | Cooley LLP | Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Fish & Richardson P.C. | Fried Frank, Harris, Shriver & Jacobson LLP | Irell & Manella LLP | Fenwick & West LLP
Kirkland & Ellis LLP | Morrison & Foerster LLP | Weil, Gotshal & Manges LLP | WilmerHale
Wolf, Greenfield & Sacks, P.C. | Wilson Sonsini Goodrich & Rosati